Intellectual Property India Publishes Patent Application for Endogenous Endoplasmic Reticulum Targeting Signal Peptides And Uses Thereof

MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617052533 A) filed by The Board Of Regents Of The University Of Texas on April 24, 2026, for Endogenous Endoplasmic Reticulum Targeting Signal Peptides And Uses Thereof.

Inventors include Siegwart, Daniel J.; Farbiak, Lukas; and Miller, William.

The application for the patent was published on August 07, 2026, under issue no. 32/2026.

Abstract: Provided for herein are novel recombinant polypeptides comprising endogenous signal peptides targeting the endoplasmic reticulum of a cell and a payload protein, nucleic acid molecules encoding the same, pharmaceutical compositions comprising the same, and methods of use thereof.

Disclaimer: Curated by HT Syndication.